Redness, itching, or mild irritation at the application site can occur, particularly during initial use or with higher concentrations
Known and theoretical safety concerns include: Retatrutide (and the GLP-1 receptor agonist class): Nausea, vomiting, diarrhoea, and reduced appetite are the most commonly reported side effects
TOP SELLING PRODUCTS Researched Benefits: AOD 9604 5MG is a research peptide referenced in scientific literature as a modified peptide fragment derived from human growth hormone
It helps convert the food you eat into energy, supports your nervous system, and assists in DNA production
For hematocrit and reticulocyte counts, recommendations are to repeat these tests daily from the 5th to 7th days of treatment and then frequently until the hematocrit returns to a normal range (11, 14, 15)